LAM30171

LAM30171 is a synthetic fatty acid derivative and small molecule developed by Laminar Pharmaceuticals for the treatment of cancer and metabolic disorders. The drug utilizes a novel therapeutic approach known as melitherapy (Membrane Lipid Therapy or MLT), which focuses on modulating the composition and structure of cell membrane lipids rather than directly targeting proteins or nucleic acids. By altering the membrane lipid environment, LAM30171 regulates the localization and activity of key peripheral membrane proteins involved in intracellular signaling pathways that drive disease progression. This mechanism aims to correct aberrant signaling associated with serious diseases, providing a unique therapeutic strategy in oncology and metabolic medicine.